Astellas Pharma
Company Details
Linkedin ID:
astellaspharmainc
Website:
Employees number:
11,951
Number of followers:
651,651
NAICS:
3254
Industry Type:
Homepage:
astellas.com
IP Addresses:
0
Company ID:
AST_1093412
Scan Status:
In-progress
Astellas Pharma Company CyberSecurity Posture
astellas.com
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines
Astellas Pharma A.I CyberSecurity Scoring
Astellas Pharma Risk Score (AI oriented)Between 750 and 799
Astellas Pharma
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Astellas Pharma Global Score (TPRM)XXXX
Astellas Pharma
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Astellas Pharma Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Astellas Pharma Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Astellas Pharma
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Astellas Pharma in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Astellas Pharma in 2025.
Incident Types Astellas Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Astellas Pharma in 2025.
Incident History — Astellas Pharma (X = Date, Y = Severity)
Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries
Astellas Pharma Company Subsidiaries
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines
Loading...
Astellas Pharma Similar Companies
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc
MANKIND PHARMA LTD
Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing,
Cipla
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp
Hetero Drugs Ltd
Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa
Merck Group
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye ca
Grifols
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions i
.png)
Astellas Pharma CyberSecurity News
October 07, 2025 03:05 PM
Astellas Careers: Work With Purpose in Science & Innovation
Explore Astellas careers and job openings worldwide, and join a team driven by science, collaboration, and a mission to improve patients' lives.
June 26, 2025 07:00 AM
Major boost for Munster's pharma sector as Japanese giant invests €129m
Astellas, one of Japan's largest life sciences companies, confirmed today that it will invest €129m in its Irish operations over the next three years.
September 23, 2024 07:00 AM
The White House, Microsoft, SaS, Foley Hoag & Astellas Offer AI Guidance to Investors. Part One: The Present
Before companies and investors look towards the future, they must first understand the opportunities and challenges AI presents to them.
March 06, 2024 08:00 AM
Digital Transformation Summit 2025: Australia's future in evolving digital landscape - The Australia
The 36th Edition of the Digital Transformation Summit is taking place on March 12, 2025, at the Hilton Sydney.
January 30, 2023 08:00 AM
Microsoft surpasses $20B in security revenue as enterprise customers consolidate
The company's cybersecurity business is growing, but CEO Satya Nadella warned that customers, in an uncertain economy, are exercising...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Astellas Pharma CyberSecurity History Information
Official Website of Astellas Pharma
The official website of Astellas Pharma is http://www.astellas.com/.
Astellas Pharma’s AI-Generated Cybersecurity Score
According to Rankiteo, Astellas Pharma’s AI-generated cybersecurity score is 796, reflecting their Fair security posture.
How many security badges does Astellas Pharma’ have ?
According to Rankiteo, Astellas Pharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Astellas Pharma have SOC 2 Type 1 certification ?
According to Rankiteo, Astellas Pharma is not certified under SOC 2 Type 1.
Does Astellas Pharma have SOC 2 Type 2 certification ?
According to Rankiteo, Astellas Pharma does not hold a SOC 2 Type 2 certification.
Does Astellas Pharma comply with GDPR ?
According to Rankiteo, Astellas Pharma is not listed as GDPR compliant.
Does Astellas Pharma have PCI DSS certification ?
According to Rankiteo, Astellas Pharma does not currently maintain PCI DSS compliance.
Does Astellas Pharma comply with HIPAA ?
According to Rankiteo, Astellas Pharma is not compliant with HIPAA regulations.
Does Astellas Pharma have ISO 27001 certification ?
According to Rankiteo,Astellas Pharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Astellas Pharma
Astellas Pharma operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Astellas Pharma
Astellas Pharma employs approximately 11,951 people worldwide.
Subsidiaries Owned by Astellas Pharma
Astellas Pharma presently has no subsidiaries across any sectors.
Astellas Pharma’s LinkedIn Followers
Astellas Pharma’s official LinkedIn profile has approximately 651,651 followers.
NAICS Classification of Astellas Pharma
Astellas Pharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Astellas Pharma’s Presence on Crunchbase
No, Astellas Pharma does not have a profile on Crunchbase.
Astellas Pharma’s Presence on LinkedIn
Yes, Astellas Pharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/astellaspharmainc.
Cybersecurity Incidents Involving Astellas Pharma
As of November 27, 2025, Rankiteo reports that Astellas Pharma has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Astellas Pharma has an estimated 5,260 peer or competitor companies worldwide.
Astellas Pharma CyberSecurity History Information
How many cyber incidents has Astellas Pharma faced ?
Total Incidents: According to Rankiteo, Astellas Pharma has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Astellas Pharma ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/angular/angular/commit/0276479e7d0e280e0f8d26fa567d3b7aa97a516f
- https://github.com/angular/angular/commit/05fe6686a97fa0bcd3cf157805b3612033f975bc
- https://github.com/angular/angular/commit/3240d856d942727372a705252f7c8c115394a41e
- https://github.com/angular/angular/releases/tag/19.2.16
- https://github.com/angular/angular/releases/tag/20.3.14
- https://github.com/angular/angular/releases/tag/21.0.1
- https://github.com/angular/angular/security/advisories/GHSA-58c5-g7wp-6w37
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=astellaspharmainc' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
